Evidence map›Paper›PMID 25612508›Full record

ArticleRadiation oncology (London, England)2015

GTV delineation in supraglottic laryngeal carcinoma: interobserver agreement of CT versus CT-MR delineation.

Elise Anne Jager, Nicolien Kasperts, Joana Caldas-Magalhaes, Mariëlle E P Philippens, Frank A Pameijer, Chris H J Terhaard, Cornelis P J Raaijmakers

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elise Anne JagerDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. e.a.jager-3@umcutrecht.nl.
Nicolien KaspertsDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. n.kasperts@umcutrecht.nl.
Joana Caldas-MagalhaesDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. j.caldasmagalhaes-2@umcutrecht.nl.
Mariëlle E P PhilippensDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. m.philippens@umcutrecht.nl.
Frank A PameijerDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. f.a.pameijer@umcutrecht.nl.
Chris H J TerhaardDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. c.h.j.terhaard@umcutrecht.nl.
Cornelis P J RaaijmakersDepartment of Radiation Oncology, University Medical Center Utrecht, Q01.118; Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. c.p.j.raaijmakers@umcutrecht.nl.
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGTV delineation is the first crucial step in radiotherapy and requires high accuracy, especially with the growing use of highly conformal and adaptive radiotherapy techniques. If GTV delineations of observers concord, they are considered to be of high accuracy. The aim of the study is to determine the interobserver agreement for GTV delineations of supraglottic laryngeal carcinoma on CT and on CT combined with MR-images and to determine the effect of adding MR images to CT-based delineation on the delineated volume and the interobserver agreement.

methodsTwenty patients with biopsy proven T1-T4 supraglottic laryngeal cancer, treated with curative intent were included. For all patients a contrast enhanced planning CT and a 1.5-T MRI with gadolinium were acquired in the same head-and-shoulder mask for fixation as used during treatment. For MRI, a two element surface coil was used as a receiver coil. Three dedicated observers independently delineated the GTV on CT. After an interval of 2 weeks, a set of co-registered CT and MR-images was provided to delineate the GTV on CT. Common volumes (C) and encompassing volumes (E) were calculated and C/E ratios were determined for each pair of observers. The conformity index general (CIgen) was used to quantify the interobserver agreement.

resultsIn general, a large variation in interobserver agreement was found for CT (range: 0.29-0.77) as well as for CT-MR delineations (range: 0.17-0.80). The mean CIgen for CT (0.61) was larger compared to CT-MR (0.57) (p = 0.032). Mean GTV volume delineated on CT-MR (6.6 cm(3)) was larger compared to CT (5.6 cm(3)) (p = 0.002).

conclusionDelineation on CT with co-registered MR-images resulted in a larger mean GTV volume and in a decrease in interobserver agreement compared to CT only delineation for supraglottic laryngeal carcinoma.

Indexed as

Observer VariationRadiotherapy, Intensity-ModulatedCarcinoma, Squamous CellGlottisHumansLaryngeal NeoplasmsMagnetic Resonance ImagingRadiotherapy DosageTomography, X-Ray Computed

Identifiers

PMID25612508
PMCPMC4327804
OpenAlexW2118763826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.